Dermapharm Holding SE
XETRA:DMP
Dermapharm Holding SE
XETRA:DMP
Price:
34.45
EUR
-1.85%
Market Closed
Market Cap:
€1.9B
Relative Value
The Relative Value of one
DMP
stock under the Base Case scenario is
49.59
EUR.
Compared to the current market price of 34.45 EUR,
Dermapharm Holding SE
is
Undervalued by 31%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
DMP
Relative Value
Base Case
49.59
EUR
Undervaluation 31%
Multiples Across Competitors
DMP Competitors Multiples
Dermapharm Holding SE Competitors
Dermapharm Holding SE Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| DE |
|
Dermapharm Holding SE
XETRA:DMP
|
1.9B EUR | 1.6 | 16.2 | 8.7 | 12.2 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
947.4B USD | 16 | 51.5 | 34.6 | 37.1 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
564B USD | 6 | 21 | 14.6 | 17.9 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
282B CHF | 4.6 | 30 | 12.7 | 14.8 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
214.9B GBP | 5.1 | 31.7 | 15.1 | 22.1 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
290.3B USD | 4.5 | 15.2 | 10.7 | 12.7 | |
| CH |
|
Novartis AG
SIX:NOVN
|
225.6B CHF | 5.2 | 20.2 | 12.7 | 16.4 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.6T DKK | 5.2 | 15.9 | 11 | 12.8 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD | 94 | -74.6 | 333.1 | 835.4 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
145.7B USD | 2.3 | 14.8 | 7.5 | 10.3 | |
| FR |
|
Sanofi SA
PAR:SAN
|
98B EUR | 1.7 | 8.2 | 7.7 | 7.7 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
